You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for HALOPERIDOL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for HALOPERIDOL

Average Pharmacy Cost for HALOPERIDOL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
HALOPERIDOL LAC 2 MG/ML CONC 72888-0173-48 0.19394 ML 2025-03-19
HALOPERIDOL LAC 2 MG/ML CONC 72888-0173-47 0.88254 ML 2025-03-19
HALOPERIDOL DEC 100 MG/ML VIAL 72603-0230-01 19.12289 ML 2025-03-19
HALOPERIDOL DEC 500 MG/5 ML VL 71288-0504-05 20.19846 ML 2025-03-19
HALOPERIDOL DEC 100 MG/ML VIAL 71288-0503-02 14.55320 ML 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for HALOPERIDOL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)UnitDatesPrice Type
HALOPERIDOL 5MG/ML (PF) INJ Golden State Medical Supply, Inc. 00143-9501-25 25X1ML 39.80 2023-06-23 - 2028-06-14 FSS
HALOPERIDOL 2MG/ML SOLN,ORAL Golden State Medical Supply, Inc. 00121-0581-04 118ML 19.40 0.16441 ML 2023-06-15 - 2028-06-14 FSS
HALOPERIDOL 2MG TAB AvKare, LLC 69292-0584-01 100 11.11 0.11110 EACH 2023-06-15 - 2028-06-14 FSS
HALOPERIDOL 5MG TAB AvKare, LLC 69292-0586-01 100 9.95 0.09950 EACH 2023-06-15 - 2028-06-14 FSS
HALOPERIDOL 5MG/ML (PF) INJ Sagent Pharmaceuticals 25021-0806-01 10X1ML 6.03 2024-05-01 - 2029-04-30 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Unit>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 5 of 5 entries

Market Analysis and Price Projections for Haloperidol

Introduction to Haloperidol

Haloperidol, commonly known by the brand name Haldol, is a miscellaneous antipsychotic agent used primarily to treat mental health disorders such as schizophrenia, bipolar disorder, and other psychotic conditions. It is available in various forms, including oral tablets and injectable solutions.

Market Size and Growth

The global haloperidol market is anticipated to experience significant growth over the forecast period from 2024 to 2032. Here are some key points regarding the market size and growth:

  • Global Market Size: The haloperidol market is expected to expand at a notable Compound Annual Growth Rate (CAGR) during the forecast period, reaching multimillion USD by 2032 compared to 2022[1][4].
  • Regional Growth: The market is segmented geographically into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. Each region is expected to contribute to the overall growth, with the US and Canada, China, and Europe showing substantial increases in market value[1][4].

Types and Applications of Haloperidol

Haloperidol is categorized based on its types and applications:

  • Types:
    • Oral: Available in various strengths such as 0.5 mg, 1 mg, 5 mg, 10 mg, and 20 mg tablets[2][5].
    • Injection: Includes intramuscular solutions with concentrations of 5 mg/mL, 50 mg/mL, and 100 mg/mL[2][5].
  • Applications:
    • Mental Disease: Primarily used for treating schizophrenia, bipolar disorder, and other mental health disorders[1][3][4].
    • Others: May be used for conditions such as dementia, ICU agitation, and mania[5].

Price Projections

The pricing of haloperidol varies based on the form and concentration of the drug:

  • Oral Tablets:
    • Prices range from approximately $26.50 for 100 tablets of 1 mg to $47.75 for 100 tablets of 20 mg[2].
    • For example, a 10 mg tablet can cost between $0.32 and $0.55 per unit for a 100-tablet supply[2].
  • Injectable Solutions:
    • The cost for a 5 mg/mL injectable solution can be around $19.66 for 10 milliliters, while a 100 mg/mL solution can cost between $37.04 and $47.60 per milliliter[2][5].
    • For instance, a 10-milliliter supply of 5 mg/mL solution can cost around $225, depending on the pharmacy[5].

Market Drivers and Challenges

Several factors are driving the growth of the haloperidol market:

  • Increasing Prevalence of Mental Health Disorders: The rise in mental health issues such as schizophrenia and bipolar disorder is a significant driver[3].
  • Advancements in Drug Development: Innovations in drug development, including the introduction of new antipsychotic medications, are contributing to market growth[3].
  • Growing Awareness About Mental Health: Increased awareness and reduced stigma around mental health issues are leading to higher demand for antipsychotic medications like haloperidol[3].

However, the market also faces some challenges:

  • Side Effects and Safety Concerns: Haloperidol is associated with side effects such as extrapyramidal symptoms, which can impact its adoption[3].
  • Competition from Other Antipsychotics: The market is competitive, with other antipsychotic medications like aripiprazole and brexpiprazole gaining traction[3].

Competitive Landscape

The global haloperidol market is dominated by several key manufacturers:

  • Sandoz
  • Mylan
  • Teva
  • Fresenius Kabi
  • Gland Pharma
  • Zydus

These companies play a significant role in the market, with the top five players holding a substantial share of the revenue in 2022[1][4].

Regional Market Analysis

The market is segmented into several regions, each with its own growth trajectory:

  • North America: Expected to see significant growth due to the high prevalence of mental health disorders and advanced healthcare infrastructure[1][4].
  • Europe: Also anticipated to grow, driven by increasing awareness and treatment of mental health conditions[1][4].
  • Asia-Pacific: This region is expected to show rapid growth due to a large patient population and increasing healthcare spending[1][4].

Future Outlook

The future outlook for the haloperidol market is positive, driven by several factors:

  • Continued Growth in Mental Health Treatment: The increasing focus on mental health and the growing need for effective treatments will drive the demand for haloperidol[3].
  • Innovations in Drug Delivery: Advances in drug delivery systems, such as extended-release formulations, will enhance the market[3].

Key Takeaways

  • The haloperidol market is expected to grow significantly from 2024 to 2032.
  • The market is driven by the increasing prevalence of mental health disorders and advancements in drug development.
  • Oral and injectable forms of haloperidol are available, with varying price points.
  • Key manufacturers include Sandoz, Mylan, Teva, Fresenius Kabi, Gland Pharma, and Zydus.
  • Regional markets such as North America, Europe, and Asia-Pacific are expected to contribute substantially to the overall growth.

FAQs

1. What are the primary uses of haloperidol? Haloperidol is primarily used to treat mental health disorders such as schizophrenia, bipolar disorder, and other psychotic conditions. It is also used for conditions like dementia and ICU agitation[5].

2. What are the different forms of haloperidol available? Haloperidol is available in oral tablets (various strengths) and injectable solutions (5 mg/mL, 50 mg/mL, and 100 mg/mL)[2][5].

3. Who are the key manufacturers of haloperidol? The key manufacturers include Sandoz, Mylan, Teva, Fresenius Kabi, Gland Pharma, and Zydus[1][4].

4. What is the expected growth rate of the haloperidol market? The haloperidol market is expected to expand at a notable CAGR from 2024 to 2032, reaching multimillion USD by 2032[1][4].

5. What are the main drivers of the haloperidol market? The main drivers include the increasing prevalence of mental health disorders, advancements in drug development, and growing awareness about mental health issues[3].

Sources

  1. Haloperidol Market 2024 Identify Business Strategies Upto 2032 - Central News Channel Nebraska[1]
  2. Haloperidol Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com[2]
  3. Antipsychotic Drugs Market Size And Share Report, 2030 - Grand View Research[3]
  4. Global Haloperidol Market Size, Trends and Projections - Market Research Intellect[4]
  5. Haldol Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.